GSK PLC

GS70

Company Profile

  • Business description

    In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

  • Contact

    79 New Oxford Street
    LondonWC1A 1DG
    GBR

    T: +44 2080475000

    E: [email protected]

    https://www.gsk.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - General

    Fiscal Year End

    31 December 2025

    Employees

    68,629

Stocks News & Analysis

stocks

Nvidia: Collaboration with Intel might bring some goodwill with the US

We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.
stocks

What now for Santos after takeover offer collapses?

Our Fair Value estimate once again reflects the stand-alone business and its growth potential.
stocks

Morningstar initiates coverage on small cap ASX REIT

Coverage of ASX listed REIT as investor interest in property continues to grow.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,061.2020.50-0.23%
CAC 407,853.591.02-0.01%
DAX 4023,639.4135.12-0.15%
Dow JONES (US)46,315.27172.850.37%
FTSE 1009,216.6711.44-0.12%
HKSE26,545.100.250.00%
NASDAQ22,631.48160.750.72%
Nikkei 22545,045.81257.62-0.57%
NZX 50 Index13,231.66111.630.85%
S&P 5006,664.3632.400.49%
S&P/ASX 2008,773.5018.70-0.21%
SSE Composite Index3,820.0911.57-0.30%

Market Movers